Published in Virology on October 01, 1995
The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol (1996) 3.89
Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci U S A (1996) 2.18
Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J Virol (1996) 1.62
trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J Virol (2004) 1.57
DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol (1998) 1.49
Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J Virol (1998) 1.25
Production and characterization of vaccines based on flaviviruses defective in replication. Virology (2006) 1.24
Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J Virol (2003) 1.12
Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J Gen Virol (2007) 1.09
Production of pseudoinfectious yellow fever virus with a two-component genome. J Virol (2007) 1.09
Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J Virol (2013) 1.05
Development of a rubella virus vaccine expression vector: use of a picornavirus internal ribosome entry site increases stability of expression. J Virol (2000) 0.96
A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition. J Virol (2010) 0.96
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice. J Virol (2007) 0.95
Alphavirus-based vaccines. Viruses (2014) 0.84
Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line. Virol J (2007) 0.84
Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes. J Virol (1997) 0.83
Properties and use of novel replication-competent vectors based on Semliki Forest virus. Virol J (2009) 0.82
Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus. J Virol (2017) 0.75
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum (1977) 9.14
SWINE INFLUENZA : II. A HEMOPHILIC BACILLUS FROM THE RESPIRATORY TRACT OF INFECTED SWINE. J Exp Med (1931) 9.13
NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA. J Exp Med (1936) 8.25
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06
Neurologic abnormalities of Lyme disease. Medicine (Baltimore) (1979) 3.98
THE ETIOLOGY OF SWINE INFLUENZA. Science (1931) 3.88
AN INTERMEDIATE HOST FOR THE SWINE INFLUENZA VIRUS. Science (1939) 3.87
"MAD ITCH" OF CATTLE. Science (1930) 2.90
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol (1995) 2.66
Two African viruses serologically and morphologically related to rabies virus. J Virol (1970) 2.62
Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol (2001) 2.59
Bunyaviridae. Intervirology (1980) 2.53
Thottapalayam virus: a presumptive arbovirus isolated from a shrew in India. Indian J Med Res (1971) 2.52
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol (1997) 2.51
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol (1993) 2.50
Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution. Virology (1990) 2.36
Oligonucleotide fingerprints of RNA species obtained from rhabdoviruses belonging to the vesicular stomatitis virus subgroup. J Virol (1977) 2.35
PSEUDORABIES AS A CONTAGIOUS DISEASE IN SWINE. Science (1934) 2.27
Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology (1991) 2.17
Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology (1992) 2.15
The importance of inorganic phosphate in regulation of energy metabolism of Streptococcus lactis. J Biol Chem (1981) 2.05
Detection of antibodies to alphaviruses by enzyme-linked immunosorbent assay. J Clin Microbiol (1979) 2.01
Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus. Intervirology (1980) 1.98
Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol (1993) 1.97
Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol (1999) 1.94
Venezuelan haemorrhagic fever. Lancet (1991) 1.90
Formation of recombinants between snowshoe hare and La Crosse bunyaviruses. J Virol (1977) 1.87
Epidemiological aspects of the 1969 yellow fever epidemic in Nigeria. Bull World Health Organ (1972) 1.86
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America. Am J Trop Med Hyg (1999) 1.83
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies. J Gen Virol (1971) 1.78
THE ANTIBODY RESPONSE TO SWINE INFLUENZA. J Exp Med (1939) 1.77
Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology (1992) 1.76
Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol (2000) 1.70
Electron microscopic and antigenic studies of uncharacterized viruses. II. Evidence suggesting the placement of viruses in the family Bunyaviridae. Arch Virol (1989) 1.67
An antiviral substance from Penicillium funiculosum. V. Induction of interferon by helenine. J Exp Med (1966) 1.63
Detection of La Crosse arbovirus antigen in mosquito pools: application of chromogenic and fluorogenic enzyme immunoassay systems. J Clin Microbiol (1982) 1.62
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61
A CHANGE IN RABBIT FIBROMA VIRUS SUGGESTING MUTATION : III. INTERPRETATION OF FINDINGS. J Exp Med (1936) 1.61
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. J Gen Virol (1971) 1.56
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology (1991) 1.55
Genetic variation in yellow fever virus: duplication in the 3' noncoding region of strains from Africa. Virology (1996) 1.53
Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J Infect Dis (1995) 1.46
Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol (2000) 1.44
Recurrence of Rift Valley fever in Egypt. Lancet (1993) 1.44
Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine (1994) 1.43
Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol (1995) 1.42
An antiviral substance from Penicillium funiculosum. IV. Inquiry into the mechanism by which helenine exerts its antiviral effect. J Exp Med (1966) 1.40
Attenuation of virulence of a bunyavirus involving an L RNA defect and isolation of LAC/SSH/LAC and LAC/SSH/SSH reassortants. Virology (1981) 1.39
Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology (1987) 1.39
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol (1996) 1.35
Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves. Am J Vet Res (1978) 1.35
Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins. J Virol (1997) 1.33
Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol (2001) 1.33
Vaccinia-vectored expression of the rubella virus structural proteins and characterization of the E1 and E2 glycosidic linkages. Virology (1991) 1.31
Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup. Lancet (1980) 1.29
Molecular cloning and sequencing of the region of the rubella virus genome coding for glycoprotein E1. Virology (1986) 1.27
Antigenic relationships among rhabdoviruses from vertebrates and hematophagous arthropods. Intervirology (1989) 1.26
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology (1992) 1.24
Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains. Am J Trop Med Hyg (2001) 1.23
Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol (1998) 1.23
Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol (1995) 1.23
Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology (1982) 1.23
Mayaro virus fever in French Guiana: isolation, identification, and seroprevalence. Am J Trop Med Hyg (1998) 1.22
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
Characterization of the rubella virus nonstructural protease domain and its cleavage site. J Virol (1996) 1.22
The spread of Rift Valley fever and approaches to its control. Bull World Health Organ (1982) 1.22
Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants. Virology (1995) 1.21
Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg (1994) 1.21
Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J Virol (1994) 1.21
Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts. J Virol (1994) 1.21
Time course of virus-specific macromolecular synthesis during rubella virus infection in Vero cells. Virology (1988) 1.20
Jatobal virus is a reassortant containing the small RNA of Oropouche virus. Virus Res (2001) 1.20
Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology (2001) 1.19
Evaluation of vero cell lysate antigen for the ELISA of flaviviruses. J Clin Lab Anal (1993) 1.19
Identification of the rubella virus nonstructural proteins. Virology (1995) 1.17
Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine (1998) 1.16
Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am J Vet Res (1987) 1.15
Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine (2000) 1.15
Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus. Virology (2001) 1.15
Expression of the rubella virus nonstructural protein ORF and demonstration of proteolytic processing. Virology (1994) 1.13
Mutagenic analysis of the 3' cis-acting elements of the rubella virus genome. J Virol (1999) 1.12
A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice. Vaccine (2000) 1.12
Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J Virol (2001) 1.12
Molecular basis of bunyavirus transmission by mosquitoes: role of the middle-sized RNA segment. Science (1981) 1.11
Biophysical studies on circle formation by Sindbis virus 49 S RNA. J Mol Biol (1979) 1.11
Expression of Japanese encephalitis virus antigens in Escherichia coli. Virology (1987) 1.08
The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1991) 1.08